Sponsors

Increasing workflow efficiency with HbA1c testing on the DxC 700 AU

Uncontrolled diabetes is associated with serious health problems including cardiovascular disease, neuropathy, nephropathy and retinopathy, and, as such, is a significant burden to the NHS. It is estimated that 8.6% of the adult population in England have diabetes, with this figure expected to rise to 9.7% by 2035.

In 2011 the World Health Organization recommended the use of glycated haemoglobin (HbA1c) as a diagnostic test for diabetes, with levels ≥48 mmol/mol considered the cut-off. The increasing prevalence and the increased utility of the HbA1c test as a diagnostic tool has led to a dramatic increase in laboratory requests. Use of Beckman’s DxC 700 AU analyser has helped a laboratory on Teesside manage this increased demand, as Helen Verrill, Consultant Clinical Scientist at North Tees & Hartlepool NHS Foundation Trust, will explain in the December issue of Pathology in Practice.

Latest Issues

GenQA at ESCV 2025

Thessaloniki Concert Hall
17 September, 2025

IBMS Congress

The International Convention Centre (ICC), Birmingham
22-25 September, 2025

Diagnostics North East Conference 2025

The Catalyst, Newcastle
3 October